Europe Faces Surge in Antibiotic-Resistant Blood Infections, Study Warns
Table of Contents
A new study published in PLOS Medicine predicts a significant rise in antibiotic-resistant blood infections across Europe by 2030, with older adults particularly vulnerable. The research highlights a critical gap in current public health modeling: the insufficient consideration of age and sex as determining factors in infection rates.
A looming public health crisis is on the horizon for Europe, as a British study reveals a projected increase in blood infections caused by bacteria no longer responding to antibiotics. The primary driver of this surge is the continent’s aging population, a demographic trend that is poised to exacerbate the challenge of antimicrobial resistance.
Unequal Burden: Age, Sex, and Geography Matter
Researchers from the London School of Hygiene & Tropical Medicine analyzed data from over 12 million blood tests conducted across 29 European countries between 2010 and 2019. By integrating this extensive dataset with demographic projections extending to 2050, they were able to forecast the evolving incidence of resistant blood infections.
The model reveals a concerning trend: a marked increase in cases is anticipated among men in six of the eight bacterial types studied. However, the most significant increases are predicted among individuals over the age of 74. “Our study shows that the future burden of resistant infections will not be uniform,” one researcher stated. “We see the largest increases among older people, particularly those over 65. Preventing a further increase would already be a great success for public health.”
International Goals at Risk
Despite global health initiatives aimed at curbing antimicrobial resistance, achieving ambitious targets is proving difficult. Researchers estimate that a 10% reduction in resistant infections by 2030 – a goal set by the United Nations – will only be attainable for approximately two-thirds of bacteria-antibiotic combinations.
A key finding of the study is that current models often underestimate the scale of the problem by failing to adequately account for demographic factors like age and gender. Ignoring these variables could lead to ineffective interventions and a greater public health impact.
“What we found most interesting was to connect different types of data to create a global overview,” the scientists added. “Age and gender are still rarely taken into account in antimicrobial resistance projections, even though they really influence the populations most affected.”
For the authors, this research represents a significant advancement in understanding the future trajectory of resistant infections. “This is a major step forward in understanding how age and sex will influence the burden of resistant infections in the years to come,” they concluded. “This will allow interventions to be targeted to populations most at risk, in order to reduce mortality and morbidity.”
Targeted interventions, informed by a more nuanced understanding of risk factors, are now crucial to mitigate the impending crisis and protect vulnerable populations across Europe.
